A new in vitro model of hepatitis C virion production: application of basic research on hepatitis C virus to clinical medicine
-
- Saito Satoru
- Gastroenterology Division, Yokohama City University School of Medicine, Japan Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, USA
-
- Heller Theo
- Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, USA
-
- Yoneda Masato
- Gastroenterology Division, Yokohama City University School of Medicine, Japan
-
- Takahashi Hirokazu
- Gastroenterology Division, Yokohama City University School of Medicine, Japan
-
- Nakajima Atsushi
- Gastroenterology Division, Yokohama City University School of Medicine, Japan
-
- Liang Jake T.
- Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, USA
書誌事項
- タイトル別名
-
- Lifestyle-Related Diseases of the Digestive System: A New In Vitro Model of Hepatitis C Virion Production: Application of Basic Research on Hepatitis C Virus to Clinical Medicine
この論文をさがす
抄録
The hepatitis C virus (HCV) is an enveloped virus with a single positive-strand RNA genome of about 9.6 kb. It is a major cause of liver disease worldwide. Clear understanding of the viral life cycle has been hampered by the lack of a robust cell culture system. While the development of the HCV replicon system was a major breakthrough, infectious virions could not be produced with the replicon system. Recently, several groups have reported producing HCV virions using in vitro systems. One of these is a replicon system, but with the special genotype 2a strain JFH-1. Another is a DNA transfection system, with the construct containing the cDNA of the known infectious HCV genotype 1b flanked by two ribozymes. The development of these models further extends the repertoire of tools available for the study of HCV biology, and in particular, they may help to elucidate the molecular details of hepatitis C viral assembly and release. This review discusses the progression of experimental strategies related to HCV and how these strategies may be applied to clinical medicine.<br>
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 105 (2), 138-144, 2007
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205179858560
-
- NII論文ID
- 10024316065
-
- NII書誌ID
- AA11806667
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 8965946
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可